365 related articles for article (PubMed ID: 21889558)
1. Contacts with children and young people and adult risk of suffering herpes zoster.
Salleras M; Domínguez A; Soldevila N; Prat A; Garrido P; Torner N; Borrás E; Salleras L
Vaccine; 2011 Oct; 29(44):7602-5. PubMed ID: 21889558
[TBL] [Abstract][Full Text] [Related]
2. Family history and herpes zoster risk in the era of shingles vaccination.
Hernandez PO; Javed S; Mendoza N; Lapolla W; Hicks LD; Tyring SK
J Clin Virol; 2011 Dec; 52(4):344-8. PubMed ID: 21924676
[TBL] [Abstract][Full Text] [Related]
3. Herpes zoster vaccine and the incidence of recurrent herpes zoster in an immunocompetent elderly population.
Tseng HF; Chi M; Smith N; Marcy SM; Sy LS; Jacobsen SJ
J Infect Dis; 2012 Jul; 206(2):190-6. PubMed ID: 22669900
[TBL] [Abstract][Full Text] [Related]
4. Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study.
Thomas SL; Wheeler JG; Hall AJ
Lancet; 2002 Aug; 360(9334):678-82. PubMed ID: 12241874
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the incidence of herpes zoster after concomitant administration of zoster vaccine and polysaccharide pneumococcal vaccine.
Tseng HF; Smith N; Sy LS; Jacobsen SJ
Vaccine; 2011 May; 29(20):3628-32. PubMed ID: 21435407
[TBL] [Abstract][Full Text] [Related]
6. [Modelling the impact of vaccination on the epidemiology of varicella zoster virus].
Bonmarin I; Santa-Olalla P; Lévy-Bruhl D
Rev Epidemiol Sante Publique; 2008 Oct; 56(5):323-31. PubMed ID: 18951741
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of vaccination against herpes zoster in adults aged over 60 years in Belgium.
Bilcke J; Marais C; Ogunjimi B; Willem L; Hens N; Beutels P
Vaccine; 2012 Jan; 30(3):675-84. PubMed ID: 22120193
[TBL] [Abstract][Full Text] [Related]
8. Varicella zoster virus redux.
Gelb LD
Herpes; 2009 Jan; 15(3):62-3. PubMed ID: 19306605
[TBL] [Abstract][Full Text] [Related]
9. Zoster vaccine: current status and future prospects.
Oxman MN
Clin Infect Dis; 2010 Jul; 51(2):197-213. PubMed ID: 20550454
[TBL] [Abstract][Full Text] [Related]
10. Safety, tolerability, and immunogenicity of zoster vaccine in subjects with a history of herpes zoster.
Mills R; Tyring SK; Levin MJ; Parrino J; Li X; Coll KE; Stek JE; Schlienger K; Chan IS; Silber JL
Vaccine; 2010 Jun; 28(25):4204-9. PubMed ID: 20416263
[TBL] [Abstract][Full Text] [Related]
11. Chickenpox vaccines: new drugs. A favourable risk-benefit balance in some situations.
Prescrire Int; 2005 Jun; 14(77):85-91. PubMed ID: 15977369
[TBL] [Abstract][Full Text] [Related]
12. Herpes zoster vaccination among adults aged 60 years and older, in the U.S., 2008.
Lu PJ; Euler GL; Harpaz R
Am J Prev Med; 2011 Feb; 40(2):e1-6. PubMed ID: 21238856
[TBL] [Abstract][Full Text] [Related]
13. Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: uptake of the first new vaccine to target seniors.
Lu PJ; Euler GL; Jumaan AO; Harpaz R
Vaccine; 2009 Feb; 27(6):882-7. PubMed ID: 19071175
[TBL] [Abstract][Full Text] [Related]
14. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.
de Melker H; Berbers G; Hahné S; Rümke H; van den Hof S; de Wit A; Boot H
Vaccine; 2006 May; 24(18):3946-52. PubMed ID: 16564115
[TBL] [Abstract][Full Text] [Related]
15. No evidence of family history as a risk factor for herpes zoster in patients with post-herpetic neuralgia.
Gatti A; Pica F; Boccia MT; De Antoni F; Sabato AF; Volpi A
J Med Virol; 2010 May; 82(6):1007-11. PubMed ID: 20419815
[TBL] [Abstract][Full Text] [Related]
16. [Prevention of herpes zoster by vaccination].
Kofoed K; Rønholt F; Gerstoft J; Sand C
Ugeskr Laeger; 2011 Jan; 173(2):110-4. PubMed ID: 21219841
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
Pellissier JM; Brisson M; Levin MJ
Vaccine; 2007 Nov; 25(49):8326-37. PubMed ID: 17980938
[TBL] [Abstract][Full Text] [Related]
18. Micronutrient intake and the risk of herpes zoster: a case-control study.
Thomas SL; Wheeler JG; Hall AJ
Int J Epidemiol; 2006 Apr; 35(2):307-14. PubMed ID: 16330478
[TBL] [Abstract][Full Text] [Related]
19. Vaccination: a new option to reduce the burden of herpes zoster.
Mick G
Expert Rev Vaccines; 2010 Mar; 9(3 Suppl):31-5. PubMed ID: 20192716
[TBL] [Abstract][Full Text] [Related]
20. The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination.
Civen R; Chaves SS; Jumaan A; Wu H; Mascola L; Gargiullo P; Seward JF
Pediatr Infect Dis J; 2009 Nov; 28(11):954-9. PubMed ID: 19536039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]